Femten ud af 120 (13%) patienter i REYATAZ + ritonavir- behandlingsarmen og 17 ud af 123 (14%) patienter i lopinavir + ritonavir - armen havde fire eller flere af PI- substitutionerne L10, M46, I54, V82, I84 og L90.
Fifteen of 120 (13%) patients in the REYATAZ + ritonavir treatment arm and 17 of 123 (14%) patients in the lopinavir + ritonavir arm had four or more of the PI substitutions L10, M46, I54, V82, I84, and L90.